Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $22.31 USD
Change Today -0.02 / -0.09%
Volume 189.0K
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert A. Copeland Ph.D.

Chief Scientific Officer and President of Research, Epizyme, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Robert A. Copeland, also known as Bob, Ph.D., has been the Chief Scientific Officer at Epizyme, Inc. since September 2008 and its President of Research since January 2015 and served as its Executive Vice President since September 2008. Dr. Copeland joined Epizyme in September, 2008. He served as the Vice President of Cancer Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline. He served scientific staff positions at Merck Research Laboratories, ...

Read Full Background

Corporate Headquarters*

400 Technology Square
Cambridge, Massachusetts 02139

United States

Phone: 617-229-5872
Fax: 617-349-0707

Board Members Memberships*

There is no Board Members Memberships data available.


Princeton University
Post-Doctoral Training
California Institute of Technology
Seton Hall University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$531,684

Stock Options*

All Other Compensation$6,390
Exercisable Options85,554
Unexercisable Options83,226
Total Number of Options168,780

Total Compensation*

Total Annual Cash Compensation$538,074
Total Short Term Compensation$531,684
Other Long Term Compensation$6,390
Total Calculated Compensation$1,188,016
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EPZM:US $22.31 USD -0.02


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EPIZYME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at